Thermo Fisher Scientific EBITDA Margin 2010-2022 | TMO

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Thermo Fisher Scientific (TMO) over the last 10 years. The current EBITDA margin for Thermo Fisher Scientific as of June 30, 2022 is .
Thermo Fisher Scientific EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2022-06-30 $42.82B $12.64B 29.53%
2022-03-31 $41.12B $12.63B 30.71%
2021-12-31 $39.21B $12.62B 32.18%
2021-09-30 $39.06B $13.07B 33.47%
2021-06-30 $38.25B $13.17B 34.42%
2021-03-31 $35.89B $12.31B 34.29%
2020-12-31 $32.22B $10.12B 31.41%
2020-09-30 $28.50B $8.25B 28.96%
2020-06-30 $26.25B $6.77B 25.81%
2020-03-31 $25.65B $6.88B 26.81%
2019-12-31 $25.54B $6.87B 26.90%
2019-09-30 $25.22B $6.77B 26.84%
2019-06-30 $24.87B $6.72B 27.03%
2019-03-31 $24.63B $6.16B 25.03%
2018-12-31 $24.36B $6.05B 24.84%
2018-09-30 $23.90B $5.88B 24.58%
2018-06-30 $23.09B $5.55B 24.04%
2018-03-31 $22.01B $5.27B 23.94%
2017-12-31 $20.92B $4.99B 23.87%
2017-09-30 $19.82B $4.70B 23.69%
2017-06-30 $19.20B $4.52B 23.54%
2017-03-31 $18.74B $4.37B 23.30%
2016-12-31 $18.27B $4.22B 23.07%
2016-09-30 $17.97B $4.10B 22.78%
2016-06-30 $17.61B $4.11B 23.36%
2016-03-31 $17.34B $4.06B 23.38%
2015-12-31 $16.97B $4.03B 23.73%
2015-09-30 $16.81B $3.98B 23.68%
2015-06-30 $16.85B $4.08B 24.23%
2015-03-31 $16.91B $3.85B 22.78%
2014-12-31 $16.89B $4.19B 24.80%
2014-09-30 $15.86B $3.82B 24.10%
2014-06-30 $14.89B $3.37B 22.65%
2014-03-31 $13.80B $3.21B 23.28%
2013-12-31 $13.09B $2.61B 19.94%
2013-09-30 $12.88B $2.56B 19.88%
2013-06-30 $12.78B $2.52B 19.68%
2013-03-31 $12.65B $2.50B 19.76%
2012-12-31 $12.51B $2.47B 19.70%
2012-09-30 $12.30B $2.40B 19.54%
2012-06-30 $12.15B $2.35B 19.36%
2012-03-31 $11.90B $2.21B 18.57%
2011-12-31 $11.56B $2.11B 18.26%
2011-09-30 $11.05B $2.00B 18.08%
2011-06-30 $10.75B $1.94B 18.03%
2011-03-31 $10.49B $1.96B 18.64%
2010-12-31 $10.39B $1.93B 18.54%
2010-09-30 $10.49B $1.91B 18.16%
2010-06-30 $10.40B $1.89B 18.20%
2010-03-31 $10.28B $1.86B 18.11%
2009-12-31 $9.91B $1.76B 17.80%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $204.040B $39.211B
Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions Segment, Analytical Instruments, and Specialty Diagnostics.
Stock Name Country Market Cap PE Ratio
Edwards Lifesciences (EW) United States $52.534B 37.17
Alcon (ALC) Switzerland $29.415B 24.91
STERIS (STE) Ireland $16.731B 20.78
Teleflex (TFX) United States $9.732B 15.51
Fresenius Medical Care AG KGaA (FMS) Germany $8.433B 7.78
Penumbra (PEN) United States $7.007B 840.64
Globus Medical (GMED) United States $5.801B 29.59
Glaukos (GKOS) United States $2.385B 0.00
Integer Holdings (ITGR) United States $2.051B 16.04
Nevro (NVRO) United States $1.548B 0.00
Paragon 28 (FNA) United States $1.343B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.035B 15.85
Artivion (AORT) United States $0.537B 51.19